Use of osteoporosis drugs have dropped following media reports of safety concerns

Following a decade of steady growth, use of bisphosphonates—medications that are effective for treating osteoporosis—declined in the United States by more than 50% from 2008 to 2012.

The sudden drop seemed to occur after media reports highlighted safety concerns, such as the development of certain fractures that occurred rarely in long-term users, despite the fact that the US Food and Drug Administration and the American Society of Bone and Mineral Research did not recommend any specific safety restrictions on . The findings are published in the Journal of Bone and Mineral Research.

"Our study documents a dramatic drop in medication use by patients. Whether it will impact the long-term bone health of the nation remains to be seen," said senior author Dr. Timothy Bhattacharyya.


Explore further

Osteoporosis drugs' long-term use needs more research, FDA reports

More information: Journal of Bone and Mineral Research, DOI: 10.1002/jbmr.2565
Provided by Wiley
Citation: Use of osteoporosis drugs have dropped following media reports of safety concerns (2015, June 15) retrieved 27 June 2019 from https://medicalxpress.com/news/2015-06-osteoporosis-drugs-media-safety.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more